LimFlow

LimFlow is owned by Inari Medical. Inari Medical has a direct presence in 2 countries.

Acquisition, funding and merger involving Inari Medical.

• Inari Medical has acquired LimFlow (posted on November 16 2023).
• Inari Medical has announced the acquisition of LimFlow  (posted on November 6 2023).

View the org chart displaying its 10 main executives

Most searched biographies at LimFlow

• Dan Rose, Chief Executive Officer
• Kinam Hong, Director
• Gerard Hascöet, Director

Popular executive movements at Inari Medical

• Tim Benner has joined the company as Senior Vice President of US Sales  (posted on April 3 2024).

Create your alert
to follow the executive moves at LimFlow.

Inari Medical has 2,273 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).
• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
• Nuvation Bio has announced the acquisition of AnHeart  (posted on April 12 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by LimFlow

• Inari Medical Closes Acquisition of LimFlow | Inari Medical, Inc.
• Latest News and Results for LimFlow Studies - LimFlow

Social media about LimFlow

• LimFlow on Wikipedia, Google News & Yahoo Finance
• LimFlow on LinkedIn, Twitter & YouTube

Contact by email its executives including Sophie Humbert

Call LimFlow at +33 63...

View the org chart

Register to receive your alert

Report an error